KengoInagakiMD

Pediatric Infections Associated with Transplant/Immunocompromised States

Physician

Dr. Inagaki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of TennesseeFellowship, Pediatric Infectious Diseases, 2011 - 2014
Maimonides Medical Center/Infants and Children's Hospital of BrooklynResidency, Pediatrics, 2008 - 2011
Tokyo Medical and Dental UniversityClass of 2005

PubMed

Nephrotoxicity of Intravenous Ganciclovir in Pediatric Hematopoietic Cell Transplant Recipients.
Kengo Inagaki, Mark T Vander Lugt, Daniel Riggsbee, Jason B Weinberg
The Pediatric Infectious Disease Journal. 2024-07-23
1 citations
Mucormycosis in children with cancer and hematopoietic cell transplant-A single center cohort study.
Gabriela A Marón, Kengo Inagaki, Alicia Rodriguez, Katherine M Knapp, Randall T Hayden
Plos One. 2024-01-01
2 citations
Risk of Staphylococcus aureus Bacteremia Before and After Solid Organ Transplantation.
Kengo Inagaki, Jason B Weinberg, Daniel R Kaul
Transplantation. 2023-08-01

In Michigan, a Record-Breaking Number of Children Have Been Hospitalized with CovidApril 22nd, 2021
Ann Arbor Medical and Mental Health Doctors Want Date for in-Person School Learning OptionFebruary 8th, 2021